Balyasny Asset Management LLC Selecta Biosciences Inc Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.15 - $1.89 $32,451 - $53,333	28,219 Added 136.21%	48,936 $68,000
Q4 2022 Feb 14, 2023	BUY	$0.96 - $1.6 $19,888 - $33,147	20,717 New	20,717 $23,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $1.4 $15,840 - $33,098	23,642 New	23,642 $31,000
Q2 2018 Aug 14, 2018	SELL	$9.36 - $13.25 $211,994 - $300,099	-22,649 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$8.49 - $11.82 $19,527 - $27,186	-2,300 Reduced 9.22%	22,649 $231,000
Q4 2017 Feb 14, 2018	BUY	$8.97 - $23.38 $223,792 - $583,307	24,949	24,949 $245,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.